Jeffrey M. Jonas - Jun 15, 2021 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Jeffrey M. Jonas
Stock symbol
SAGE
Transactions as of
Jun 15, 2021
Transactions value $
-$176,468
Form type
4
Date filed
6/17/2021, 09:13 AM
Previous filing
Jun 11, 2021
Next filing
Jun 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Award $0 +10K +17.75% $0.00 66.3K Jun 15, 2021 Direct F1
transaction SAGE Common Stock Tax liability -$182K -3.09K -4.66% $58.80 63.2K Jun 15, 2021 Direct
transaction SAGE Common Stock Options Exercise $5.4K +12K +18.98% $0.45* 75.2K Jun 16, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SAGE Stock Option (Right to Buy) Options Exercise $0 -12K -20.48% $0.00 46.6K Jun 16, 2021 Common Stock 12K $0.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 25, 2020, the reporting person was granted Performance Stock Units (PSU) to acquire a total of 25,000 shares of common stock. The PSU vests upon the achievement of certain milestones, one of which was met on June 15, 2021, resulting in the vesting of the PSU as to 10,000 shares.
F2 The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on August 12, 2017.